AMA Clinical Examples in Radiology - 2019 Issue 4 (Fall)
Nuclear Medicine Renal SPECT/CT Scan
CLINICAL EXAMPLE 2 Nuclear Medicine Renal SPECT/CT Scan CLINICAL HISTORY A 10-year-old female with a renal transplant presenting with suspected renal infection. TECHNIQUE A 1.53 mCi dose of gallium-67 citrate was administered intravenously. Abdominal and pelvic planar images were obtained in multiple projections approximately 24 hours post-injection with additional delayed images at 48 hours. Single-photon emission computed tomography/computed tomography (SPECT/CT) images of the abdomen were acquired. CT images were obtained for the purposes of attenuation correction and anatomic localization and were reviewed alongside the SPECT images. FINDINGS There is focally increased uptake in the right-lower quadrant of the...
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews a renal SPECT/CT nuclear medicine case centered on infection in a transplanted kidney and discusses how the study is reported in coding terms before and after a January 1, 2020 change. It is useful for coders, billers, and imaging professionals who need to understand the general scope of the exam, the timing-based coding framework, radiopharmaceutical billing considerations, and the broader nuclear medicine terminology referenced by the article.
Why This Topic Matters
Renal nuclear medicine studies can involve multiple reporting elements that vary by service date, imaging method, and associated drug charges. Understanding the article helps users identify whether the content applies to transplant infection imaging and to the coding transition discussed for nuclear medicine inflammatory process studies.
Article Sections
-
Clinical Example 2
A renal transplant imaging case is presented with clinical context, technique, findings, and impression. The section frames the study type and the diagnostic scenario addressed by the article.
-
How to Code
This section summarizes the article’s coding framework by date of service and distinguishes the reporting approach before and after the 2020 coding changes. It also introduces associated radiopharmaceutical and diagnosis reporting considerations.
-
Discussion
The discussion gives broader background on nuclear medicine infection imaging, terminology used in the modality, and the coding transition affecting inflammatory process studies. It also addresses general radiopharmaceutical and billing concepts in nuclear medicine.
-
Coding Tip
This section provides general guidance on HCPCS Level II radiopharmaceutical supply reporting and the structure of the relevant code section. It is presented as a coding reference for nuclear medicine procedures.
What You Will Learn
- How the article frames a renal transplant nuclear medicine infection study
- What general coding topics are tied to the exam by date of service
- How the article discusses radiopharmaceutical reporting in nuclear medicine
- Which broader nuclear medicine terminology and service categories are referenced
- What transitional coding context is presented for inflammatory process imaging
Who Should Read This
- Medical coders
- Radiology billing staff
- Nuclear medicine technologists
- Radiologists
- Compliance and reimbursement professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com